Literature DB >> 10404280

Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model.

A I El-Sakka1, C S Lin, R M Chui, R Dahiya, T F Lue.   

Abstract

Erectile dysfunction occurs frequently in humans with diabetes mellitus; the molecular basis of this phenomenon is not known. We investigated the effects of diabetes on penile erection, nitric oxide synthase and growth factors expression in an animal model. Forty male rats were divided into two groups: the experimental group (n = 30) received intraperitoneal injection of Streptozotocin (STZ) dissolved in citrate buffer to induce diabetes; ten age-matched control rats received injection of citrate buffer vehicle only. Before euthanization at eight weeks, erectile function was assessed by electrostimulation of the cavernous nerves. NADPH diaphorase staining was used to identify NOS and immunostaining technique was used to identify nNOS in the penile nerve fibers. RT-PCR was used to identify mRNA expression of nNOS, eNOS, iNOS, ER-beta, ER-alpha, NGF, IGF-I, TGF-beta 1, and AR. Western blot was used to identify nNOS, IGF-I, NGF, and TFG-beta protein expressions. In the diabetic group, there was: (1) a significant decrease in NOS containing nerve fibers in the dorsal and intracavernosal nerves; (2) a significant lower maximal intracavernosal pressure. RT-PCR showed down-regulation of nNOS (large form), iNOS and ER-beta mRNA expression, Immunoblot showed down-regulation of nNOS protein expression and nNOS immunostaining showed less positive staining in the dorsal and intracavernous nerves in the diabetic group. These molecular changes may provide the basis for further studies to explore the association between diabetes and impotence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404280     DOI: 10.1038/sj.ijir.3900392

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  23 in total

Review 1.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 2.  Mesenchymal stem cell-based gene therapy for erectile dysfunction.

Authors:  J H Kim; H J Lee; Y S Song
Journal:  Int J Impot Res       Date:  2016-02-18       Impact factor: 2.896

3.  Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats.

Authors:  Chris J Sullivan; Thomas H Teal; Ian P Luttrell; Khoa B Tran; Mette A Peters; Hunter Wessells
Journal:  Physiol Genomics       Date:  2005-08-23       Impact factor: 3.107

Review 4.  Neurogenic erectile dysfunction.

Authors:  T F Lue
Journal:  Clin Auton Res       Date:  2001-10       Impact factor: 4.435

5.  Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

Authors:  I Vareniuk; I A Pavlov; I G Obrosova
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

6.  Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon.

Authors:  S Cellek; J Rodrigo; E Lobos; P Fernández; J Serrano; S Moncada
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 7.  Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action.

Authors:  Ibrahim A Abdel-Hamid
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes.

Authors:  S Cellek; W Qu; A M Schmidt; S Moncada
Journal:  Diabetologia       Date:  2003-12-16       Impact factor: 10.122

Review 9.  eNOS, metabolic syndrome and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Trends Endocrinol Metab       Date:  2009-07-31       Impact factor: 12.015

10.  Long-term high-fat consumption leads to downregulation of Akt phosphorylation of eNOS at Ser1177 and upregulation of Sirtuin-1 expression in rat cavernous tissue.

Authors:  I Tomada; R Negrão; H Almeida; D Neves
Journal:  Age (Dordr)       Date:  2013-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.